SCHEMBL7996490

SCHEMBL7996490

COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cn(C)c4ccccc34)CC2)C1=O

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 6/20 0.73
MEN1 O00255 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
KMT2A Q03164 1/20 0.63
OPRM1 P35372 5/20 0.55
OPRK1 P41145 5/20 0.55
BDKRB2 P30411 1/20 0.52
DRD2 P14416 7/20 0.51
DRD3 P35462 7/20 0.51
DRD4 P21917 6/20 0.51
OPRD1 P41143 4/20 0.51
LMNA P02545 1/20 0.48
GLA P06280 1/20 0.48
ALDH1A1 P00352 2/20 0.47
NPC1L1 Q9UHC9 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
DOCK5 Q9H7D0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29766745 0.85 OPRL1 (1.00) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7757872 0.85 OPRL1 (1.00) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7982598 0.83 OPRL1 (0.77) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7992822 0.83 OPRL1 (0.77) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7992852 0.83 OPRL1 (0.77) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7999876 0.82 OPRL1 (0.82) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7995942 0.82 OPRL1 (0.75) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7982648 0.81 OPRL1 (0.77) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7757095 0.80 OPRL1 (0.83) OPRL1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL7999841 0.80 OPRL1 (0.69) OPRL1MEN1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277991-B1 FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES NOVO NORDISK A/S (DK) 2001-08-21 US disclosed